Family Medicine · Santa Rosa, CA
NPI
1861540486
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3569 Round Barn Cir
Santa Rosa, CA, 95403
Phone (707) 303-3600
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.9M
4,857 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Daniel R Toub prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 281 prescriptions and refills. In total Daniel R Toub wrote 4,857 Medicare prescriptions that cost $3.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 281 | 291 | 31 | $1.1M |
| Atorvastatin Calcium Generic | 270 | 365 | 43 | $986 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 132 | 132 | 16 | $476K |
| Tamsulosin Hcl Generic | 113 | 145 | 19 | $801 |
| Omeprazole Generic | 104 | 121 | 13 | $441 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 99 | 99 | 13 | $4,868 |
| Benazepril Hcl Generic | 99 | 119 | 12 | $341 |
| Amlodipine Besylate Generic | 98 | 128 | 12 | $148 |
| Descovy Emtricitabine/Tenofov Alafenam | 96 | 100 | 11 | $212K |
| Gabapentin Generic | 88 | 88 | 14 | $773 |
| Tivicay Dolutegravir Sodium | 81 | 85 | 11 | $186K |
| Dovato Dolutegravir Sodium/Lamivudine | 76 | 76 | 14 | $223K |
| Jardiance Empagliflozin | 74 | 76 | Under 11 | $44K |
| Darunavir Generic | 72 | 74 | Under 11 | $62K |
| Juluca Dolutegravir/Rilpivirine | 69 | 73 | Under 11 | $245K |
Brand drugs: 1,436 claims; generic drugs: 3,405 claims; opioid claims: 165.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Daniel R Toub were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.